Filed in archive
Drugs, Vaccines and Therapeutics
by ruth on January 6, 2006
Based on these findings, the researchers then developed a new synthetic compound, HU-308, which activates CB-2 and slows the development of osteoporosis in mice. This compound forms the basis for a cannabinoid-based, anti-osteoporotic type drug which has also been found to be free of any psychoactive side effects.
Photo: Normal bone tissue with CB2 receptors is seen at left. At right is bone tissue in which CB2 is absent, showing serious bone density loss.
Source and Photo Credit: Hebrew University of Jerusalem
Tags:
osteoporosis
cannabinoid
biotech
based
against
against+osteoporosis
endocannabinoid+based
drug+again
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/13302
Mr Wong
Vote for Endocannabinoid-Based Prototype Drug Against Osteoporosis:
|
Rating: 6.67 out of 3 vote(s) cast.
|
Subscribe
Use the search to look for other interesting posts
| RSS | See all blog subscribe options |
|
What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |







